GlassScriptPhysician profile
Jinsook Kwack
NPI 1740721869
$1,373.41
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,333 · 2023: $40.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $40.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $40.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $376.50 | 2021 | |
| Abbvie INC. | $188.48 | 2021 | |
| Amarin Pharma, INC. | $128.97 | 2021 | |
| Lilly USA, LLC | $124.91 | 2021-2023 | Trulicity, Mounjaro |
| Astrazeneca Pharmaceuticals LP | $100.27 | 2021 | |
| Ironwood Pharmaceuticals, INC | $82.64 | 2021 | |
| Novo Nordisk INC | $81.75 | 2021 | |
| Nestle Healthcare Nutrition INC. | $53.09 | 2021 | |
| Genentech USA, INC. | $43.39 | 2021 | |
| Glaxosmithkline, LLC. | $38.09 | 2021 | |
| Pfizer INC. | $34.58 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.56 | 2021 | |
| Eisai INC. | $21.32 | 2021 | |
| Scilex Pharmaceuticals INC. | $20.52 | 2021 | |
| Astellas Pharma US INC | $17.13 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.45 | 2021 | |
| Sanofi-Aventis U.S. LLC | $13.76 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jinsook Kwack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.